Primary Central Nervous System Neoplasm

Primary Central Nervous System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,294 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 51–100 of 486 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04388475	Open-label Study Investigating of OKN-007 Combined With Temozolomide in Patients With Recurrent Glioblastoma	completed	Phase 2	57	Oblato, Inc.INDUSTRY	1	Aug 12, 2025	clinicaltrials
NCT01931098	Oral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) Without Prior Bevacizumab Exposure and (B) After Failing Prior Bevacizumab	completed	Phase 2	35	National Cancer Institute (NCI)NIH	1	Aug 11, 2025